These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15990619)

  • 1. Applying the recent clinical trials on primary open angle glaucoma: the developing world perspective.
    Thomas R; Kumar RS; Chandrasekhar G; Parikh R
    J Glaucoma; 2005 Aug; 14(4):324-7. PubMed ID: 15990619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
    Kobelt-Nguyen G; Gerdtham UG; Alm A
    J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
    Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
    Hitzl W; Ortner C; Hornykewycz K; Grabner G; Reitsamer HA
    Eur J Ophthalmol; 2006; 16(1):92-9. PubMed ID: 16496251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Kymes SM; Kass MA; Anderson DR; Miller JP; Gordon MO;
    Am J Ophthalmol; 2006 Jun; 141(6):997-1008. PubMed ID: 16765666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
    Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
    Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma management in developing countries: medical, laser, and surgical options for glaucoma management in countries with limited resources.
    Thomas R; Sekhar GC; Kumar RS
    Curr Opin Ophthalmol; 2004 Apr; 15(2):127-31. PubMed ID: 15021224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
    Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
    J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
    Salvetat ML; Zeppieri M; Tosoni C; Brusini P;
    Eye (Lond); 2016 Jun; 30(6):784-95. PubMed ID: 27174381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
    Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
    Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary angle closure glaucoma: a developing world perspective.
    Thomas R; Sekhar GC; Parikh R
    Clin Exp Ophthalmol; 2007; 35(4):374-8. PubMed ID: 17539793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma.
    Copt RP; Thomas R; Mermoud A
    Arch Ophthalmol; 1999 Jan; 117(1):14-6. PubMed ID: 9930155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials.
    Maier PC; Funk J; Schwarzer G; Antes G; Falck-Ytter YT
    BMJ; 2005 Jul; 331(7509):134. PubMed ID: 15994659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations Between the Individual Risk for Glaucoma and RNFL and Optic Disc Morphometrical Evaluations in Ocular Hypertensive Patients.
    Colombo L; Bertuzzi F; Rulli E; Miglior S
    J Glaucoma; 2016 May; 25(5):e455-62. PubMed ID: 26091177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
    Gordon MO; Beiser JA; Brandt JD; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Kass MA
    Arch Ophthalmol; 2002 Jun; 120(6):714-20; discussion 829-30. PubMed ID: 12049575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology.
    Dueker DK; Singh K; Lin SC; Fechtner RD; Minckler DS; Samples JR; Schuman JS
    Ophthalmology; 2007 Sep; 114(9):1779-87. PubMed ID: 17822980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of primary open-angle glaucoma and exfoliation glaucoma at diagnosis.
    Tarkkanen AH; Kivelä TT
    Eur J Ophthalmol; 2015; 25(2):137-9. PubMed ID: 25198170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian perspectives in glaucoma management: the role of central corneal thickness.
    Behki R; Damji KF; Crichton A;
    Can J Ophthalmol; 2007 Feb; 42(1):66-74. PubMed ID: 17361244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline topographic optic disc measurements are associated with the development of primary open-angle glaucoma: the Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study.
    Zangwill LM; Weinreb RN; Beiser JA; Berry CC; Cioffi GA; Coleman AL; Trick G; Liebmann JM; Brandt JD; Piltz-Seymour JR; Dirkes KA; Vega S; Kass MA; Gordon MO
    Arch Ophthalmol; 2005 Sep; 123(9):1188-97. PubMed ID: 16157798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma guidelines: help or hindrance?
    Vernon S
    Clin Exp Ophthalmol; 2009 Sep; 37(7):641-3. PubMed ID: 19788656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.